Page 2 - இந்தியன் பார்மா சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amid COVID Surge, Indian Pharma Sector Witnesses Exponential Growth In April 2021: Report

Amid COVID Surge, Indian Pharma Sector Witnesses Exponential Growth In April 2021: Report A Representative Image The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector. According to total sales audit data from worldâs largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per cent year on year (yoy) in April, 2021 vs 16 per cent yoy in March, 2021 due to the low base effect in April, 2020 and sharp surge in Covid-19-related sales. On the MAT (moving annual turnover) basis, IPM grew 9.6 per cent, primarily driven by pricing growth of 4.3 per cent and new product launch growth of 4.6 per cent. Volume growth was muted at 0.8 per cent.

Sun pharmaEmkay global financial servicesIndian pharma marketIpca labsசூரியன் பார்மாஎம்காய் உலகளாவிய நிதி சேவைகள்இந்தியன் பார்மா சந்தைஇப்க ஆய்வகங்கள்

Pharma index hits record high as govt launches phase 3 of Covid vaccination

Shares of pharmaceutical companies are in demand at the bourses with Nifty Pharma and the S&P BSE Healthcare indices gaining 2 per cent each and hitting their respective all-time highs on Tuesday as a significant resurge in Covid-19 cases across India led to spike in demand for Covid-related drugs. Individually, Cipla, Gland Pharma, JB Chemicals and Pharmaceuticals, Max Healthcare, Neuland Laboratories and Apollo Hospital Enterprises hit their respective record highs today. Menawhile, Sun Pharmaceutical Industries, Cadila Healthcare, Glenmark Pharmaceuticals, Panacea Biotech and RPG Lifesicenes are among those that hit 52-week highs in the intra-day trade today. Investors rushed to buy pharma stocks as the Indian government will open up vaccination to anyone over 18 years of age starting May 1 with greater flexibility on pricing, procurement and administration of vaccines. This opens up the private market for vaccination and provides more leeway to states and private companies.

Andhra pradeshSun pharmaceutical industriesApollo hospital enterprisesHealth canadaGlenmark pharmaceuticalsSerum institute bharat biotechNifty pharmaGland pharmaMax healthcareNeuland laboratoriesCadila healthcarePanacea biotechBharat biotechAxis capitalIndian pharma marketVivimed labs

Government s clear policy, single window clearance required to boost Gujarat s pharma machinery market | ગુજરાતના ફાર્મા મશીનરી માર્કેટને વેગ આપવા સરકારની સ્પષ્ટ નીતિ, સિંગલ વિન્ડો ક્લિયરન્સ જરૂરી

Government s clear policy, single window clearance required to boost Gujarat s pharma machinery market | ગુજરાતના ફાર્મા મશીનરી માર્કેટને વેગ આપવા સરકારની સ્પષ્ટ નીતિ, સિંગલ વિન્ડો ક્લિયરન્સ જરૂરી
divyabhaskar.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from divyabhaskar.co.in Daily Mail and Mail on Sunday newspapers.

Piyush daveIndian pharmaGujarat pharmaGujarat advance indianIndian pharma gateOverall marketPharma marketIndian pharma marketஇந்தியன் பார்மாஓவரால் சந்தைபார்மா சந்தைஇந்தியன் பார்மா சந்தை

Indian Pharma Market Expected To Grow To 130 Billion By 2030 DV Sadananda Gowda

BW Businessworld Indian Pharma Market Expected To Grow To $130 Billion By 2030: DV Sadananda Gowda India is being applauded globally in its fight against COVID, development of 7 more vaccines is in pipeline: Mansukh Mandaviya Photo Credit : Speaking at the curtain raiser event ‘India Pharma & India Medical Device 2021’ scheduled on 25-26 February & 1-2 March 2021, D V Sadananda Gowda, Minister for Chemicals and Fertilizers said the total market size of the Indian Pharma Industry is expected to reach the US $ 130 Billion by 2030. The medical devices industry in India has the potential to reach $ 50 bn by 2025. The ‘India Pharma & India Medical Device 2021’ will be the 6th edition of the annual program on the Pharmaceuticals & Medical Device sector that is jointly organized by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers with FICCI and Invest India. The theme for this year India Pharma is ‘Indian Pharma Industry - ‘Future is Now’ and for In

Narendra modiIndian pharmaAtmanirbhar bharatDv sadananda gowdaMansukh mandaviyaUnion cabinetMinistry of environmentMinistry of chemicals fertilizersDepartment of pharmaceuticals doDepartment of pharmaceuticalsScheme in pharmaceuticalsGlobal alliancePharmaceuticals medical deviceSerum institute of indiaInternational drug regulator sessionIndia pharma

Indian Pharma Market Expected To Hit $130 Billion By 2030: D V Sadananda Gowda

Following the onset of the pandemic, the Indian pharma industry has shown its role as a reliable supplier of drugs and medical devices in a time of need, D V Sadananda Gowda added.

Dv sadananda gowdaMansukh mandaviyaFertiliser ministerdv sadananda gowdaIndian pharmaIndia medical deviceFertilisers mansukh mandaviyaIndian pharma marketIndian pharmaceutical industryட்வ் சதானந்த கவுடாமன்சுக் மண்டவியாஇந்தியன் பார்மாஇந்தியா மருத்துவ சாதனம்உரங்கள் மன்சுக் மண்டவியாஇந்தியன் பார்மா சந்தைஇந்தியன் மருந்து தொழில்